At Close: 4:00 PM
NovoCure Stock Price Graph
NovoCure Stock Price Today
NovoCure Limited (NVCR) stock declined over -2.17% intraday to trade at $12.2 a share on NASDAQ. The stock opened with a gain of 10.50% at $13.16 and touched an intraday high of $13.31, rising 2.43% against the last close of $11.91. The NovoCure Limited in stock market went to a low of $12.37 during the session.
NovoCure Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
NovoCure Stock Price History Chart
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.
Frequently Asked Questions
What is the current NovoCure Limited (NVCR) stock price?
NovoCure Limited (NASDAQ: NVCR) stock price is $12.20 in the last trading session. During the trading session, NVCR stock reached the peak price of $13.31 while $12.37 was the lowest point it dropped to. The percentage change in NVCR stock occurred in the recent session was -2.17% while the dollar amount for the price change in NVCR stock was -$0.27.
NVCR's industry and sector of operation?
The NASDAQ listed NVCR is part of Medical Instruments & Supplies industry that operates in the broader Healthcare sector. NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma.
Who are the executives of NVCR?
Mr. Asaf Danziger
Pres, Chief Executive Officer & Director
Ms. Ingrid Goldberg
Vice President of Investor Relations
Mr. Pritesh Shah
Chief Commercial Officer
Prof. Yoram Palti M.D., Ph.D.
Founder & Chief Technology Officer
How NVCR did perform over past 52-week?
NVCR's closing price is 0.19% higher than its 52-week low of $12.37 where as its distance from 52-week high of $120.03 is -0.44%.
How many employees does NVCR have?
Number of NVCR employees currently stands at N/A. NVCR operates from No. 4 The Forum, Saint Helier, JE2 4UF, JE.
Link for NVCR official website?
Official Website of NVCR is: https://www.novocure.com
How do I contact NVCR?
How many shares of NVCR are traded daily?
NVCR stock volume for the day was 1306594.00 shares. The average number of NVCR shares traded daily for last 3 months was 1.89 Million.
What is the market cap of NVCR currently?
The market value of NVCR currently stands at $1.3 Billion with its latest stock price at $12.20 and N/A of its shares outstanding.